Clinical trial

The Efficacy and Safety Study in Patients With Type 2 Diabetes Mellitus

NCT01608724

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-11-01

PhasePHASE4

Study timeline

Study start (unknown)2012-11-01Date precision: month

Registry last updated2016-02-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Non-Insulin-Dependentunresolved

Interventions

SaxagliptinDRUG · verified · RxNorm: saxagliptin

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

BeijingChina1 ShanghaiChina1 GuangzhouChina1 TianjinChina1 ChengduChina1 HangzhouChina1 NanjingChina1 WuhanChina1 ChongqingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01608724 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.